目的:构建能分泌表达人9ku颗粒溶素(granulysin)的真核质粒,为下一步利用颗粒溶素基因治疗肿瘤奠定基础.方法:以含有颗粒溶素cDNA序列的质粒为模板,通过聚合酶链反应(PCR)扩增获得含分泌肽编码基因的9ku的颗粒溶素基因片段后,定向插入真核表达载体pBudCE4.1中,获得重组表达质粒pBudCE4.1-S9K,通过PCR,双酶切及插入片段序列测定对重组质粒进行鉴定;采用RT—PCR,免疫细胞化学与Dot—ELISA法检测pBudCE4.1-S9K在RAW264.7细胞的瞬时表达与分泌.结果:成功扩增出含分泌肽编码基因的9ku的颗粒溶素基因片段;经酶切,PCR及测序鉴定证明得到读码框正确的重组质粒;转染细胞证实可分泌表达9ku颗粒溶素.结论:成功构建能分泌表达9ku颗粒溶素真核表达质粒pBudCE4.1-S9K.
AIM: To construct secreting eukaryotic expression plasmid carrying human 9 ku-granulysin gene and to lay a foundation for the study of granulysin as anti-tumor gene therapy agent. METHODS: After amplified by PCR from the plasmid including granulysin complementary deoxyribonucleic acid (cDNA) , 9 kugranulysin gene fragment carrying leader peptide gene was cloned into pBudCFA. 1 to construct recombinant plasmid pBudCFA. 1- S9K. Identification of pBudCFA. 1-S9K was conducted by PCR , restriction enzyme digestion and sequencing. The recombinant plasmid was transfected into RAW264. 7 cells, and its transient expression was detected by RT -PCR, immunocytochemistry and Dot-ELISA. RESULTS: 9 ku-granulysin gene fragment including leader peptide gene was obtained ; it was confirmed that gene was inserted into eukaryotic expression plasmid correctly; 9 ku-granulusin can be expressed and secreted in transfected cells. CONCLUSION: Eukaryotic expression plasmid pBudCE 4.1-S9K carrying human 9 ku-granulysin gene was constructed successfully.